Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1999
08/19/1999WO1999041362A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically
08/19/1999WO1999041359A1 Modified adenovirus containing a fiber replacement protein
08/19/1999WO1999041358A1 A prokaryotic cell comprising two copies of a gene transcribed in different directions
08/19/1999WO1999041355A2 Hiv chemokines
08/19/1999WO1999041284A1 Secreted proteins and polynucleotides encoding them
08/19/1999WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999WO1999041271A1 High affinity nucleic acid ligands of complement system proteins
08/19/1999WO1999041258A1 Novel dimerizing agents, their production and use
08/19/1999WO1999041007A2 Method and apparatus for chemical and biochemical reactions using photo-generated reagents
08/19/1999WO1999040946A2 Methods and compositions for modulating leptin activity
08/19/1999WO1999040934A1 Strategically modified hepatitis b core proteins and their derivatives
08/19/1999WO1999040928A1 Novel mixed amylin activity compounds
08/19/1999WO1999040881A2 Specific antibodies against mammary tumor-associated mucin, method for production and use
08/19/1999WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999WO1999040783A1 Method of controlling proliferation and differentiation of stem and progenitor cells
08/19/1999WO1999036432A3 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof
08/19/1999WO1999033998A3 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof
08/19/1999WO1999033985A3 C1F150/hTAFII150 IS NECESSARY FOR CELL CYCLE PROGRESSION
08/19/1999WO1999031255A3 Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes
08/19/1999WO1999031250A3 Constitutive expression of non-infectious hiv-like particles
08/19/1999WO1999031224A3 Fusion proteins for use in enzymatic synthesis of oligosaccharides
08/19/1999WO1999029871A3 Circovirus sequences related to piglet weight loss disease (pwd)
08/19/1999WO1999025844A9 Mammalian cell death preventing kinase, dpk
08/19/1999WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof
08/19/1999WO1999025380A3 Methods and compositions for the treatment of psoriasis
08/19/1999WO1999024621A3 Methods and compositions for detection of specific nucleotide sequences
08/19/1999WO1999024058A3 Neuronal uses of bmp-11
08/19/1999WO1999023236A9 Method of dna shuffling
08/19/1999WO1999023227A3 Hyaluronan synthase gene and uses thereof
08/19/1999WO1999023108A9 Inducible phosphofructokinase and the warburg effect
08/19/1999WO1999021415A9 Nuclear transfer for production of transgenic animal embryo
08/19/1999WO1999020753A3 Peptide bond formation using nucleic acid catalysts
08/19/1999WO1999016907A3 Reagent and method for attaching target molecules to a surface
08/19/1999WO1999012945A3 Hydrophobic glycosylamine derivatives, compositions, and methods for use
08/19/1999WO1999005159A3 Staphylococcus specific nucleic acid molecule, test kit and utilization of the nucleic acid molecule and test kit
08/19/1999WO1999004266A3 Interactions of atm, atr or dna-pk with p53
08/19/1999WO1998055110A3 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION
08/19/1999DE19805788A1 New promoter for the human iodine-transporter gene, used to increase radioactive iodine uptake in tumor cells
08/19/1999DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer
08/19/1999CA2745932A1 Methods for predicting pregnancy outcome in a subject by hcg assay
08/19/1999CA2723040A1 Compositions comprising viruses and methods for concentrating virus preparations
08/19/1999CA2521289A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/19/1999CA2321259A1 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis
08/19/1999CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999CA2321135A1 Modified adenovirus containing a fiber replacement protein
08/19/1999CA2321105A1 Human short-chain tnf-receptor family protein
08/19/1999CA2321097A1 Anti-viral vectors
08/19/1999CA2321095A1 Nucleotide sequences encoding maize rad51
08/19/1999CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999CA2320958A1 Antigen library immunization
08/19/1999CA2320806A1 Members of the d52 gene family
08/19/1999CA2320784A1 Members of the d52 gene family
08/19/1999CA2320626A1 Genetic vaccine vector engineering
08/19/1999CA2320618A1 Secreted proteins and polynucleotides encoding them
08/19/1999CA2320517A1 Expression vector for the production of dead proteins
08/19/1999CA2320515A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999CA2320513A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
08/19/1999CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999CA2320427A1 Human receptor proteins
08/19/1999CA2320424A1 Human transport-associated molecules
08/19/1999CA2320422A1 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
08/19/1999CA2320420A1 Promoter inductible in plants, sequence incorporating same and resulting product
08/19/1999CA2320401A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase
08/19/1999CA2320391A1 Novel cystine knot protein and materials and methods for making it
08/19/1999CA2320389A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically
08/19/1999CA2320383A1 Hiv chemokines
08/19/1999CA2320226A1 Methods and compositions for modulating leptin activity
08/19/1999CA2320031A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/19/1999CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999CA2319688A1 Specific antibodies against mammary tumor-associated mucin, method for production and use
08/19/1999CA2319492A1 Novel dimerizing agents, their production and use
08/19/1999CA2319212A1 Methods for purified aav vector production
08/19/1999CA2319167A1 Interaction between cyclin d1 and steroid receptor co-activators
08/19/1999CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999CA2319065A1 Method for diagnosis and treatment of disorders of carbohydrate metabolism
08/19/1999CA2318737A1 Methods for pseudoadenoviral vector production
08/19/1999CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999CA2312991A1 Prostate-associated serine protease
08/19/1999CA2286747A1 H2-o modified transgenic animals
08/18/1999EP0936271A1 Calcium-activated potassium channel beta subunit gene and protein
08/18/1999EP0936270A2 Serin protease from prostate
08/18/1999EP0935757A1 Assessment of cervical cells
08/18/1999EP0935756A2 Monitoring reactivity of thyroid peroxidase autoantibodies
08/18/1999EP0935678A1 METHODS FOR TREATING BIPOLAR MOOD DISORDER ASSOCIATED WITH MARKERS ON CHROMOSOMES 18p
08/18/1999EP0935677A1 Method for preparing assay supports having an ordered set of reaction zones
08/18/1999EP0935676A2 Method of identifying cytochrome p450
08/18/1999EP0935675A1 Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
08/18/1999EP0935674A1 Method for diagnosis of genetic diseases by molecular combing and diagnosis box
08/18/1999EP0935671A1 Methods for preparing arrays of single-stranded dna
08/18/1999EP0935666A1 Methods for altering the rate of plant development and plants obtained therefrom
08/18/1999EP0935665A1 Encapsulation of polypeptides within the starch matrix
08/18/1999EP0935664A2 New systems for regulating genetic expression
08/18/1999EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists
08/18/1999EP0935662A2 Multiple epitope fusion protein
08/18/1999EP0935661A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation
08/18/1999EP0935660A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
08/18/1999EP0935659A1 Compositions and methods for treating intracellular diseases
08/18/1999EP0935658A1 Genetic control of flowering
08/18/1999EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids